-- Robert Preidt
THURSDAY, Feb. 3 (HealthDay News) -- A single dose of the H1N1
swine flu vaccine was 93 percent effective during the 2009
pandemic, a new study found.
In order to assess the effectiveness of the vaccine -- known as
the AS03-adjuvanted pandemic H1N1 vaccine -- Canadian researchers
looked at 552 patients with flu-like illness who visited clinics in
four provinces between Nov. 8 and Dec. 5, 2009.
Pandemic H1N1 was detected in 209 (38 percent) of the patients.
Two (1 percent) of the patients with H1N1 flu had received a single
dose of the H1N1 vaccine at least two weeks before they became ill,
compared with 58 (17 percent) of patients who didn't have H1N1
The findings show that the vaccine was 93 percent effective,
said the researchers, who were led by Danuta Skowronski at the
British Columbia Centre for Disease Control in Vancouver.
The findings apply not only to Canada but other countries where
vaccines were used, and may help guide the further development of
influenza vaccine options, the researchers said.
More than 80 percent of the people in the study were younger
than 50, so evidence of the effectiveness of the vaccine in the
elderly is still needed, they noted.
The study appeared in the Feb. 3 online edition of
The U.S. Centers for Disease Control and Prevention has more
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.